First Venture Technologies Corp.

First Venture Technologies Corp.

July 11, 2007 13:28 ET

First Venture Reports Ethyl Carbamate Reductions from 2007 Commercial Product Trials in South America

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 11, 2007) - First Venture Technologies Corp. (TSX VENTURE:FEB) is pleased to report positive results from commercial product trials of its urea-degrading wine yeasts conducted in Chile during the spring 2007 winemaking season.

"As with our USA trials during the 2006 harvest, our proprietary yeasts performed as expected in real-world field trials in which the yeasts were put through a wide range of commercial winemaking conditions," said Dr. John Husnik, a senior research scientist with First Venture. "The independent analyses, performed by a leading South American wine lab, revealed ethyl carbamate reductions ranging as high as 76% - 92% when comparing wines made with First Venture's proprietary yeasts with control yeast strains used under similar conditions, and when measuring the potential ethyl carbamate formation risk."

We continue to be very pleased with the cooperation and commitment of the global wine industry, now including the Chilean wine community, to minimize ethyl carbamate contaminant exposure in wine-based beverages," said Andy Starr, First Venture Yeast Products, Inc.'s Director of Marketing and Business Development.

In February 2007, the World Health Organization's International Agency for Research on Cancer ("IARC") upgraded ethyl carbamate to a Group 2A probable carcinogen in humans after a re-evaluation by an IARC Monograph Working Group of 26 expert scientists from 15 countries.


Howard Louie, President and CEO


First Venture is a biotechnology company that develops and commercializes advanced yeast products.

The company is currently commercializing a platform yeast technology that substantially reduces the formation of a known carcinogen, ethyl carbamate (or urethane) from food products and alcoholic beverages. The company has licensed the exclusive worldwide rights to the technology from The University of British Columbia (UBC).

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information